MeSH tree: E02.095
Researchers have developed an implant that could deliver next-generation therapies for ovarian cancer precisely where they are needed while simultaneously monitoring how the disease responds.
9 hours ago
0
3
A little-known group of hard-to-find immune cells could help transform cancer treatment, scientists at the University of Manchester's Cancer Research UK Manchester Institute have found. Their discovery, accepted for publication ...
12 hours ago
0
2
Cleveland Clinic and IBM researchers are using quantum computing to tackle one of the most challenging problems in immuno-oncology: predicting which tumor mutations will trigger an immune response.
Jul 30, 2026
0
5
Recurrent urinary tract infections (rUTIs) are among the most common bacterial infections worldwide and primarily affect women. While antibiotics remain the standard treatment, frequent recurrences and rising antibiotic resistance ...
Jul 30, 2026
0
9
A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it surgically removed. The treatment also kept ...
Jul 28, 2026
0
146
Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, ...
Jul 24, 2026
0
7
A 6-year-old Chinese girl died last year after receiving an experimental gene therapy to correct a non-life-threatening condition, according to an investigation by Science and Retraction Watch.
Jul 24, 2026
0
153
Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them. KAIST researchers have now ...
Jul 24, 2026
0
7
Sickle cell disease causes premature aging of blood stem cells, which scientists may be able to address with a special class of drugs, according to a new study from St. Jude Children's Research Hospital. Patients with sickle ...
Jul 23, 2026
0
7
In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Jul 22, 2026
0
9
